02268.HK
WuXi XDC Cayman Inc
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 72.80
−0.41%Aug 27, 2026, 10:13 UTC
WuXi AppTec sold 53.524 million shares of WuXi XDC via block trades for about HK$3.92 billion, expecting an impact of about 3.143 billion yuan on 2026 pre-tax profit.
Aug 26, 2026, 02:13 UTC
WuXi XDC signed a new licensing collaboration with a European biotech company in August 2026.
Source:Aug 25, 2026, 03:33 UTC
WuXi XDC's stock price surged over 13% to a near one-year high of HK$79 in morning trading on August 25, 2026.
Source:Aug 24, 2026, 15:16 UTC
WuXi XDC (02268.HK) announced its interim results for the six months ended June 30, 2026, with revenue of RMB 3.701 billion, up 37% year-on-year, and net profit of RMB 819 million, up 9.9%, with no dividend declared.